Profiling China’s Innovative Bio-Pharma Industry Sector in 2005

Dublin (PRWEB) February 16, 2006 -- Research and Markets (http://www.researchandmarkets.com/reports/c32775) has announced the addition of China Bio-Pharma Profiles 2005 to their offering

A brand new report that profiles China's innovative bio-pharma industry sector and its pipeline of new drugs and therapies.

The growth of this innovative sector is being driven by Chinese entrepreneurs returning from the USA to set up new companies and China's advantage as a dynamic, fast-moving economy.

In order to provide access to this sector, we have produced the definitive guide to licensing, partnership, investment and outsourcing opportunities. This groundbreaking, 190-page publication contains detailed profiles of leading Chinese bio-pharma companies, with a focus on innovation. The profiles cover business background, products on sale, product and technology pipelines, research programmes, patent portfolios and outsourcing services.

Key features include:
- Pipeline detailing 104 drugs and therapies in development
- Multiple licensing and partnering opportunities
- New developments in gene therapy, therapeutic vaccines and drug discovery
- 34 comprehensive profiles of China's leading bio-pharma companies
- Special section on IPR by Marks & Clerk
- Outsourcing section profiling a wide range of bio-pharma services
- Introduction covers industry dynamics and key findings
- Pipeline and service tables are categorised by indication/type

The report has been compiled from primary data and interviews carried out in China. All Chinese language data has been translated in-house.

For more information visit http://www.researchandmarkets.com/reports/c32775

Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980

###